GCMS
More information
WebinarsAbout usContact usTerms of use
LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike

Analysis of Designer Drugs Bath Salts by Quadrupole Ion Trap GC/MS

Applications | 2012 | Agilent TechnologiesInstrumentation
GC/MSD, GC/IT
Industries
Forensics
Manufacturer
Agilent Technologies

Summary

Significance of the Topic



Designer stimulant drugs marketed as “bath salts” have proliferated in the illicit drug market, presenting serious challenges for forensic laboratories. Rapid emergence of new analogs requires analytical methods that are both highly specific and sensitive to support legal and public health responses.

Objectives and Study Overview



This study aims to develop and validate a targeted gas chromatography–quadrupole ion trap mass spectrometry (GC/Q-IT MS) method for the simultaneous analysis of 29 common bath salt compounds. The focus is on achieving low detection limits, minimizing matrix interference, and boosting confidence in forensic identifications.

Methodology and Instrumentation



Sample Preparation and Standards:
  • 29-analyte mixture prepared at 100 ng/mL in ethyl acetate.
  • No derivatization required due to adequate volatility.

GC Conditions:
  • Instrument: Agilent 7890A GC.
  • Column: HP-5MS UI, 30 m × 0.25 mm, 0.25 µm film.
  • Injection: Pulsed splitless, 280 °C, 40 psi pulse for 0.8 min.
  • Carrier gas: Helium at 1.2 mL/min constant flow.
  • Oven program: 80 °C initial; 10 °C/min to 150 °C; 5 °C/min to 180 °C; 10 °C/min to 300 °C, total run 27 min.

MS Conditions:
  • Instrument: Agilent 240 Quadrupole Ion Trap.
  • Ionization: Electron impact (EI) full scan 35–500 Da; chemical ionization (CI) 150–400 Da using acetonitrile reagent gas.
  • Temperatures: Trap 230 °C, manifold 100 °C, transfer line 280 °C.
  • Acquisition targets: EI 40,000 counts, CI 15,000 counts; filament currents 10 µA and 20 µA respectively.

Key Results and Discussion



The optimized method achieved baseline separation of all 29 analytes with unique retention times and selected quantitation ions for both EI and CI modes. Typical detection levels reached 10 ng/mL. CI mode significantly reduced co-eluting matrix interferences, as demonstrated with the Naphyrone example, and provided cleaner molecular ion signals. A comprehensive table of retention times, molecular ions, and quantification ions under EI and CI ensures robust identification and limits false positives/negatives.

Benefits and Practical Applications



The GC/Q-IT MS approach offers:
  • High specificity through combined EI and CI spectra.
  • Low limits of detection suitable for forensic casework.
  • Rapid analysis with a 27-minute run time.
  • Reduced matrix effects and enhanced confidence in results.

This targeted method supports routine forensic screening and confirmation of designer stimulants.

Future Trends and Opportunities



Advances may include:
  • Expansion to include newly emerging bath salt analogs.
  • Integration of MS/MS workflows for even greater selectivity.
  • High-throughput automation and direct coupling with data management systems.
  • Portable ion trap MS for field screening applications.

Conclusion



This work demonstrates that GC coupled with a quadrupole ion trap mass spectrometer provides a robust, sensitive, and selective solution for the forensic analysis of bath salts. The dual-mode acquisition (EI and CI) enhances identification confidence and streamlines laboratory workflows in response to evolving designer drug threats.

References



1. DEA Public Affairs. Chemicals Used in “Bath Salts” Now Under Federal Control and Regulation. October 21, 2011.
2. Agilent Technologies, Inc. Identification of Designer Drugs by GC/MS. Application Compendium, February 2012.
3. Agilent Technologies, Inc. Confirmation and Quantification of Synthetic Cannabinoids in Herbal Incense Blends by Triple Quadrupole GC/MS. Application Note 5990-8987EN, January 2012.
4. Crifasi J., Honnold R. Ion Trap GC-MS/MS Analysis of Designer Drugs in Biological Matrix. SOFT-TIAFT Conference Poster, September 2011.

Content was automatically generated from an orignal PDF document using AI and may contain inaccuracies.

Downloadable PDF for viewing
 

Similar PDF

Toggle
ANALYSIS OF DESIGNER STIMULANTS BY GC/MS
ANALYSIS OF DESIGNER STIMULANTS BY GC/MS
2016|Agilent Technologies|Guides
ANALYSIS OF DESIGNER STIMULANTS BY GC/MS Application Compendium 1 This page intentionally blank Table of Contents Introduction ..........................................................................................................................4 Sample Preparation/Extraction ............................................................................................5 Gas Chromatograph and Mass Spectrometer Conditions ...................................................6 2,5-dimethoxy-4-bromoamphetamine ................................................................................7 2,5-dimethoxy-4-chloroamphetamine .................................................................................8 2,5-dimethoxy-4-ethylphenethylamine ................................................................................9 2,5-dimethoxy-4-ethylthiophenethylamine .......................................................................10 2,5-dimethoxy-4-iodophenethylamine ..............................................................................11 2,5-dimethoxy-4-methylamphetamine ..............................................................................12…
Key words
abundance, abundancebath, bathmbdb, mbdbstimulants, stimulantssalts, saltsintentionally, intentionallyenforcement, enforcementdesigner, designermdea, mdeacompendium, compendiumtemp, tempamu, amubenzodioxyolybutanamine, benzodioxyolybutanaminemethylbenzodioxolylbutanamine, methylbenzodioxolylbutanaminepyrovalerone
Ion Trap GC-MS/MS Analysis of “Bath Salts” in Biological Samples
Ion Trap GC-MS/MS Analysis of “Bath Salts” in Biological Samples Joseph Crifasi1, Christopher Long1, Ronald Honnold*2, Anthony Macherone2 1St. Louis University Forensic Toxicology Lab, St Louis, MO, USA, 2Agilent Technologies, Santa Clara, CA, USA Introduction Experimental Results Results and and…
Key words
mdpv, mdpvbrai, braiood, oodnaphyrone, naphyronever, verion, iondev, devprecursor, precursorbath, bathintra, intrastd, stdinter, intersalts, saltsamd, amdlouis
Bath Salt Characterization using the Tekmar HT3 Headspace Analyzer and GC/MS
Bath Salt Characterization using the Tekmar HT3 Headspace Analyzer and GC/MS Application Note Roger Bardsley Abstract With chemists engineering new “designer drugs” everyday, law enforcement and regulatory bodies need testing to quickly and accurately determine the composition of these compounds.…
Key words
bath, bathsalt, saltcharacterization, characterizationpressurize, pressurizetemp, tempequil, equilusing, usingtime, timebardsley, bardsleypowder, powdermpd, mpdmethylenedioxypyrovalerone, methylenedioxypyrovaleronefill, fillvariable, variabledsq
Extraction of Amphetamine and Designer Amphetamine Analogues from Whole Blood Using ISOLUTE® SLE+ Prior to GC/MS Analysis
Application Note AN855 Extraction of Amphetamine and Designer Amphetamine Analogues from Whole Blood by ISOLUTE SLE+ | Page 1 ® Extraction of Amphetamine and Designer Amphetamine Analogues from Whole Blood Using ISOLUTE SLE+ Prior to GC/MS Analysis ® Sample Preparation…
Key words
amphetamine, amphetamineisolute, isolutesle, sletfmpp, tfmppbiotage, biotageevaporate, evaporatenaphyrone, naphyronebzp, bzpextraction, extractiontabless, tablessbutylone, butylonelloq, lloqethylone, ethylonemethedrone, methedronemethcathinone
Other projects
LCMS
ICPMS
Follow us
More information
WebinarsAbout usContact usTerms of use
LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike